Related Experiment Videos
Haemostatic factors and atherogenesis
1Department of Clinical Biochemistry, Medical School, Foresterhill, Aberdeen, UK.
Atherosclerosis
|August 2, 1996
Summary
Fibrinolysis and clotting factors like tissue plasminogen activator (tPA) and thrombin significantly impact vascular health and atherosclerosis. These factors interact with cells and matrix, influencing vascular pathology and cell behavior.
Area of Science:
- Vascular Biology
- Hemostasis and Thrombosis
- Cellular Interactions
Background:
- Fibrin deposition and lysis are critical in vascular pathology, including atherosclerosis.
- Clinical use of fibrinolytic agents and restenosis post-angioplasty have heightened interest in hemostatic components.
Purpose of the Study:
- To review the interactions of key fibrinolytic factors (tPA, uPA, PAI-1) and thrombin with cells and extracellular matrix.
- To highlight recent findings on these interactions in vascular pathology.
Main Methods:
- Review of studies from the past 5 years.
- Analysis of interactions with endothelial and smooth muscle cells (in vitro and in vivo).
- Examination of interactions with arterial extracellular matrix, particularly fibrin.
Main Results:
- Plasminogen activators bind to cell receptors, affect cell migration, and release thrombin from fibrin.
- Thrombin acts as a versatile factor influencing endothelial and smooth muscle cell functions.
- Thrombin modulates fibrinolytic component release/synthesis and stimulates cell proliferation.
Conclusions:
- Key fibrinolytic factors and thrombin play multifaceted roles beyond fluid-phase clotting.
- These factors actively engage with cellular and matrix components in the vasculature.
- Understanding these interactions is crucial for addressing vascular pathology and restenosis.